However, in another study, the deletion of Itgfb8 was able restore the MGnD response and reduce plaque burden in AD mice, making the ITGB8-TGFβ signaling pathway a potential target for a therapeutic approach [53,157]. This evidence concerns the gene TGFB1 and Alzheimer disease.